Cargando…

Effect of Neoadjuvant Chemotherapy in Patients with Resectable Colorectal Liver Metastases

BACKGROUND: Whether patients with resectable colorectal liver metastases (CRLM) receive survival benefit from neoadjuvant chemotherapy remains controversial. METHODS: We retrospectively analyzed 466 patients with resectable CRLM between 2000 and 2010. Patient characteristics and survival data were r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Dexiang, Zhong, Yunshi, Wei, Ye, Ye, Lechi, Lin, Qi, Ren, Li, Ye, Qinghai, Liu, Tianshu, Xu, Jianmin, Qin, Xinyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897724/ https://www.ncbi.nlm.nih.gov/pubmed/24466143 http://dx.doi.org/10.1371/journal.pone.0086543

Ejemplares similares

Timing of Hepatectomy for Resectable Synchronous Colorectal Liver Metastases: For Whom Simultaneous Resection Is More Suitable - A Meta-Analysis
por: Feng, Qingyang, et al.
Publicado: (2014)

Determinants of Long-Term Outcome in Patients Undergoing Simultaneous Resection of Synchronous Colorectal Liver Metastases
por: Lin, Qi, et al.
Publicado: (2014)

Tumor deposit is a poor prognostic indicator in patients who underwent simultaneous resection for synchronous colorectal liver metastases
por: Lin, Qi, et al.
Publicado: (2015)

Efficacy of continued cetuximab for unresectable metastatic colorectal cancer after disease progression during first-line cetuximab-based chemotherapy: a retrospective cohort study
por: Feng, Qingyang, et al.
Publicado: (2016)

Resection of colorectal liver metastases following neoadjuvant chemotherapy
por: Chiappa, A, et al.
Publicado: (2007)

Anatomical resection improves relapse-free survival in colorectal liver metastases in patients with KRAS/NRAS/BRAF mutations or right-sided colon cancer: a retrospective cohort study
por: Chang, Wenju, et al.
Publicado: (2023)

Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases
por: Ichida, Hirofumi, et al.
Publicado: (2019)

Surgical resection of pulmonary metastases from colorectal cancer: 11 years of experiences
por: Cao, Guoquan, et al.
Publicado: (2017)

Is neoadjuvant chemotherapy necessary for patients with initially resectable colorectal liver metastases in the era of effective chemotherapy?
por: Son, Sang-Yong, et al.
Publicado: (2011)

Outcome of Microscopic Incomplete Resection (R1) of Colorectal Liver Metastases in the Era of Neoadjuvant Chemotherapy
por: Ayez, Ninos, et al.
Publicado: (2011)

The role of neoadjuvant chemotherapy for resectable colorectal liver metastases: a systematic review and meta-analysis
por: Liu, Wei, et al.
Publicado: (2016)

Efficacy of neoadjuvant chemotherapy for initially resectable colorectal liver metastases: A retrospective cohort study
por: Takeda, Kazuhisa, et al.
Publicado: (2022)

Upgraded nomograms for the prediction of complications and survival in patients with colorectal liver metastases treated with neoadjuvant chemotherapy followed by hepatic resection
por: Chen, Qichen, et al.
Publicado: (2021)

Differences in clinical characteristics and mutational pattern between synchronous and metachronous colorectal liver metastases
por: Zheng, Peng, et al.
Publicado: (2018)

Neoadjuvant chemotherapy for patients with resectable colorectal cancer liver metastases: A systematic review and meta-analysis
por: Zhang, Yue, et al.
Publicado: (2021)

What is the optimal number of neoadjuvant chemotherapy cycles for resectable colorectal liver oligometastases?
por: Chen, Qichen, et al.
Publicado: (2021)

Hepatic resection after neoadjuvant chemotherapy for patients with liver metastases from colorectal cancer: need for cautious planning
por: Kim, Young Il, et al.
Publicado: (2019)

Nodular Regenerative Hyperplasia Secondary to Neoadjuvant Chemotherapy for Colorectal Liver Metastases
por: van den Broek, Maartje A. J., et al.
Publicado: (2009)

Neoadjuvant chemotherapy for colorectal liver metastases: A contemporary review of the literature
por: Guo, Marissa, et al.
Publicado: (2021)

Systematic Review With Network Meta-Analysis: Adjuvant Chemotherapy for Resected Colorectal Liver Metastases
por: Zhu, Gui-Qi, et al.
Publicado: (2015)

Robotic versus open surgery for simultaneous resection of rectal cancer and liver metastases: a randomized controlled trial
por: Chang, Wenju, et al.
Publicado: (2023)

Predictive And Prognostic Value Of Hepatic Steatosis In Conversion Therapy For Colorectal Liver-limited Metastases: A Propensity Score Matching Analysis
por: Jian, Mi, et al.
Publicado: (2019)

Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases
por: Gruenberger, Birgit, et al.
Publicado: (2008)

Predictive factors of histological response of colorectal liver metastases after neoadjuvant chemotherapy
por: Serayssol, Chloé, et al.
Publicado: (2019)

Additional Biomarkers beyond RAS That Impact the Efficacy of Cetuximab plus Chemotherapy in mCRC: A Retrospective Biomarker Analysis
por: Zheng, Peng, et al.
Publicado: (2018)

Efficacy of laparoscopic liver resection in colorectal liver metastases and the influence of preoperative chemotherapy
por: Kubota, Yoshihisa, et al.
Publicado: (2014)

Efficacy of upfront hepatectomy without neoadjuvant chemotherapy for resectable colorectal liver metastasis
por: Ono, Kosuke, et al.
Publicado: (2021)

Preoperative Imaging of Colorectal Liver Metastases After Neoadjuvant Chemotherapy: A Meta-Analysis
por: van Kessel, Charlotte S., et al.
Publicado: (2012)

Impact of Neoadjuvant Chemotherapy on Clinical Risk Scores and Survival in Patients with Colorectal Liver Metastases
por: Wimmer, Kerstin, et al.
Publicado: (2016)

Deep radiomics-based fusion model for prediction of bevacizumab treatment response and outcome in patients with colorectal cancer liver metastases: a multicentre cohort study
por: Zhou, Shizhao, et al.
Publicado: (2023)

Open Right Hemicolectomy:Lateral to Medial or Medial to Lateral Approach?
por: Xu, Pingping, et al.
Publicado: (2015)

Hepatotoxicities Induced by Neoadjuvant Chemotherapy in Colorectal Cancer Liver Metastases: Distinguishing the True From the False
por: Desjardin, Marie, et al.
Publicado: (2019)

Safe liver resection following chemotherapy for colorectal metastases is a matter of timing
por: Welsh, F K S, et al.
Publicado: (2007)

Multicentre study of perioperative versus adjuvant chemotherapy for resectable colorectal liver metastases
por: Allard, M.‐A., et al.
Publicado: (2019)

ASO Author Reflections: Neoadjuvant Systemic Chemotherapy in Isolated Resectable Colorectal Peritoneal Metastases: Ready for Standard of Care?
por: Flood, Michael P., et al.
Publicado: (2022)

Liver resection for non-colorectal metastases
por: Schwarz, Christoph, et al.
Publicado: (2018)

Aberrant Scinderin Expression Correlates With Liver Metastasis and Poor Prognosis in Colorectal Cancer
por: Lin, Qi, et al.
Publicado: (2019)

Zinc-α2-glycoprotein 1 promotes EMT in colorectal cancer by filamin A mediated focal adhesion pathway
por: Ji, Meiling, et al.
Publicado: (2019)

Zinc-α2-glycoprotein 1 promotes EMT in colorectal cancer by filamin A mediated focal adhesion pathway: Erratum
por: Ji, Meiling, et al.
Publicado: (2023)

Is the Clinical Risk Score for Patients with Colorectal Liver Metastases Still Useable in the Era of Effective Neoadjuvant Chemotherapy?
por: Ayez, Ninos, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_q61dqf1mmbdrv83qvahp1vjtpo